Marsico Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-29,824
Closed -$5.02M – 69
2023
Q1
$5.02M Hold
29,824
– – 0.24% 49
2022
Q4
$5.05M Hold
29,824
– – 0.26% 50
2022
Q3
$5.58M Buy
29,824
+6,931
+30% +$1.46M 0.3% 46
2022
Q2
$3.72M Hold
22,893
– – 0.18% 63
2022
Q1
$4.31M Hold
22,893
– – 0.15% 72
2021
Q4
$6.06M Hold
22,893
– – 0.18% 65
2021
Q3
$6.62M Hold
22,893
– – 0.2% 61
2021
Q2
$4.57M Hold
22,893
– – 0.11% 72
2021
Q1
$4.45M Hold
22,893
– – 0.12% 72
2020
Q4
$4.39M Hold
22,893
– – 0.11% 76
2020
Q3
$3.38M Hold
22,893
– – 0.09% 79
2020
Q2
$2.83M Buy
+22,893
New +$2.69M 0.09% 80

Other funds holding RGEN

Marsico Capital Management's RGEN Position: Q2 2023 in Review

Marsico Capital Management sold out of Repligen (RGEN) in Q2 2023, closing a stake of 29,824 shares — an estimated $5.02M sold.

Marsico Capital Management first reported a position in RGEN in Q2 2020 and held it in 12 quarters. The position peaked at $6.62M in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Marsico Capital Management reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Marsico Capital Management sold 29,824 Repligen shares in Q2 2023, an estimated $5.02M.
  • Marsico Capital Management first reported a position in Repligen in Q2 2020 and held it in 12 quarters.
  • Marsico Capital Management's Repligen position peaked at $6.62M in Q3 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Marsico Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.